because of its potent inhibitory effects , somatostatin or somatostatin-analogues have been used as therapeutic agents in various clinical conditions , such as upper gastrointestinal haemorrhage , endocrine pancreatic tumours , gastrointestinal and pancreatic fistulas , pancreatitis , secretory diarrhoea , and dumping syndrome .
C0030274
pancreatic
C0030305
pancreatitis